Monitoring of international normalized ratios: Comparison of community nurses with family physicians

Canadian Family Physician

Volumn 58, Issue 8, 2012, Pages

  Levine, Max A ^a   Shao, Wei ^b   Klein, Douglas ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Department of Family Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

AGED; ARTICLE; CANADA; CEREBROVASCULAR ACCIDENT; CHRONIC DRUG ADMINISTRATION; COHORT ANALYSIS; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCOAGULABILITY; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NURSE; PATIENT MONITORING; RETROSPECTIVE STUDY; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; ALBERTA; ANTICOAGULANTS; COHORT STUDIES; COMMUNITY HEALTH NURSING; DRUG MONITORING; FAMILY PRACTICE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; WARFARIN;

EID: 84865438341     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Connor CA, Wright CC, Fegan CD. The safety and effectiveness of a nurse-led anticoagulant service. J Adv Nurs 2002;38(4):407-15.
2. Fitzmaurice DA, Hobbs FD, Murray ET, Holder RL, Allan TF, Rose PE. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial. Arch Intern Med 2000;160(15):2343-8.
3. Taylor FC, Gaminara E, Cohen H, Ramsay M, Miller D. Evaluation of a nurse specialist anticoagulant service. Clin Lab Haematol 1997;19(4):267-72.
4. Bungard TJ, Gardner L, Archer SL, Hamilton P, Ritchie B, Tymchak W, et al. Evaluation of a pharmacist-managed anticoagulation clinic: improving patient care. Open Med 2009;3(1):e16-21.
5. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158(15):1641-7.
6. Locke C, Ravnan SL, Patel R, Uchizono JA. Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service. Pharmacotherapy 2005;25(5):685-9.
7. Radley AS, Hall J, Farrow M, Carey PJ. Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. J Clin Pathol 1995;48(6):545-7.
8. Van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 2006;129(5):1155-66.
9. Cios DA, Baker WL, Sander SD, Phung OJ, Coleman CI. Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis. Am J Health Syst Pharm 2009;66(10):916-25.
10. Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 2005;127(5):1515-22.
11. Wilson SJ, Wells PS, Kovacs MJ, Lewis GM, Martin J, Burton E, et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 2003;169(4):293-8. Erratum in CMAJ 2004;170(4):451.
12. Francavilla CL. Registered nurse-managed anticoagulation clinic: improving patient outcomes. Nurs Econ 2008;26(2):130-2.
13. Chamberlain MA, Sageser NA, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract 2001;14(1):16-21.
14. Aziz F, Corder M, Wolffe J, Comerota AJ. Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care. J Vasc Surg 2011;25(5):1404-7. Epub 2011 Jul 7.
15. You JH, Chan FW, Wong RS, Cheng G. Cost-effectiveness of two models of management for patients on chronic warfarin therapy - a Markov model analysis. Thromb Haemost 2003;90(6):1106-11.
16. Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics 2006;24(10):1021-33.
17. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69(3):236-9.
18. Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, et al. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users. J Thromb Haemost 2010;8(4):744-9.